Philip Bligh

Co-founder & CEO at Zylem Biosciences - Chicago, Illinois, United States

Philip Bligh's Colleagues at Zylem Biosciences
Kaylin McMahon

Co-Founder and VP of Operations

Contact Kaylin McMahon

Philip Bligh's Contact Details
HQ
Location
Los Angeles,California,United States
Company
Zylem Biosciences
Philip Bligh's Company Details
Zylem Biosciences logo, Zylem Biosciences contact details

Zylem Biosciences

Chicago, Illinois, United States • 4 Employees
Research

Zylem Biosciences is a startup biotechnology company developing targeted medicines that uniquely mimic features of natural biologics. Zylem's lead compound (ZYL-001) directly targets pathologic cholesterol metabolism in cancer, heart disease and other conditions, and pathologic lipid metabolism in fatty liver disease (FLD) and obesity. ZYL-001 specifically targets a cell surface receptor to simultaneously: modulate cellular and systemic cholesterol and activate the adaptive immune system. ZYL-001 therapies are molecularly tunable and seamlessly interact with natural biological systems with no off-target toxicity. Its first-in-class mechanism of action (MOA) has been validated in small animal models of cancer and obesity.

Details about Zylem Biosciences
Frequently Asked Questions about Philip Bligh
Philip Bligh currently works for Zylem Biosciences.
Philip Bligh's role at Zylem Biosciences is Co-founder & CEO.
Philip Bligh's email address is ***@zylembio.com. To view Philip Bligh's full email address, please signup to ConnectPlex.
Philip Bligh works in the Research industry.
Philip Bligh's colleagues at Zylem Biosciences are Kaylin McMahon and others.
Philip Bligh's phone number is
See more information about Philip Bligh